Bruix, J, Sherman, M. Management of hepatocellular carcinoma: An update. Hepatology. 2011;3:1020–1022.
Goldberg, SN, Grassi, CJ, Cardella, JF, et al.
Image-guided tumor ablation: Standardization of terminology and reporting criteria. J Vasc Interv Radiol. 2009;7
Hirooka, M, Iuchi, H, Kumagi, T, et al.
Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR Am J Roentgenol. 2006;5
Rhim, H, Lee, MH, Kim, YS, et al.
Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol. 2008;5:1324–1330.
Kitada, T, Murakami, T, Kuzushita, N, et al.
Effectiveness of real-time virtual sonography-guided radiofrequency ablation treatment for patients with hepatocellular carcinomas. Hepatol Res. 2008;6:565–571.
Minami, Y, Kudo, M, Chung, H, et al.
Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology. 2007;72:111–116.
Cho, YK, Kim, JK, Kim, WT, et al.
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: A Markov model analysis. Hepatology. 2010;4:1284–1290.
Molinari, M, Helton, S. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: A Markov model decision analysis. Am J Surg. 2009;3:396–406.
Minami, Y, Chung, H, Kudo, M, et al.
Radiofrequency ablation of hepatocellular carcinoma: Value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol. 2008;6:W335–W341.
Liu, FY, Yu, XL, Liang, P, et al.
Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography. Eur J Radiol. 2012;7:1455–1459.
Nakai, M, Sato, M, Sahara, S, et al.
Radiofrequency ablation assisted by real-time virtual sonography and CT for hepatocellular carcinoma undetectable by conventional sonography. Cardiovasc Intervent Radiol. 2009;1:62–9.
Lee, MW, Rhim, H, Cha, DI, et al.
Percutaneous radiofrequency ablation of hepatocellular carcinoma: Fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;6:1438–1444.
Livraghi, T, Goldberg, SN, Lazzaroni, S, et al.
Hepatocellular carcinoma: Radio-frequency ablation of medium and large lesions. Radiology. 2000;3:761–768.
Zhou, Y, Zhao, Y, Li, B, et al.
Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol. 2010;10:78.
Scaife, CL, Curley, SA. Complication, local recurrence, and survival rates after radiofrequency ablation for hepatic malignancies. Surg Oncol Clin N Am. 2003;1:243–55.
Zhong, Y, Deng, M, Li, M, et al.
Abdominal virtual sonography combined with artificial ascite in RFA for HCC of specific sites. Hepatol Int. 2013;7:1–9.
Llovet, JM, Vilana, R, Bru, C, et al.
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;5:1124–1129.
Mulier, S, Mulier, P, Ni, Y, et al.
Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002;10:1206–1222.
de Villa, V, Lo, CM. Liver transplantation for hepatocellular carcinoma in Asia. Oncologist. 2007;11:1321–31.
McLernon, DJ, Dillon, J, Donnan, PT. Health-state utilities in liver disease: A systematic review. Med Decis Making. 2008;4:582–592.
Stein, K, Rosenberg, W, Wong, J. Cost effectiveness of combination therapy for hepatitis C: A decision analytic model. Gut. 2002;2:253–258.
Ruggeri, M, Cicchetti, A, Gasbarrini, A. The cost-effectiveness of alternative strategies against HBV in Italy. Health Policy. 2011;1:72–80.
Gazelle, GS, McMahon, PM, Beinfeld, MT, et al.
Metastatic colorectal carcinoma: Cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection. Radiology. 2004;3:729–739.
Peng, ZW, Lin, XJ, Zhang, YJ, et al.
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: A retrospective comparative study. Radiology. 2012;3:1022–1033.
Guan, ZQ, Dong, ZH, Wang, QH, et al.
Cost of chronic hepatitis B infection in China. J Clin Gastroenterol. 2004;10
Chen, D, Yao, G, Chen, W. Economic evaluation of peginterferon Alfa-2a and lamivudine in the treatment of HBeAg negative chronic hepatitis B. J Hepatol. 2014;4:1–9.
Chen, JQ, Yang, GH, Zhu, Q, et al.
An analysis of related factors of cost of inpatients with hepatic carcinoma receiving operative treatment. Chinese Hospitals. 2003;12:1–9.
Huang, J, Yan, L, Cheng, Z, et al.
A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;6:903–912.
Hung, HH, Chiou, YY, Hsia, CY, et al.
Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol. 2011;1:79–86.
Vivarelli, M, Guglielmi, A, Ruzzenente, A, et al.
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg. 2004;1:102–107.
Eichler, HG, Kong, SX, Gerth, WC, et al.
Use of cost-effectiveness analysis in health-care resource allocation decision-making: How are cost-effectiveness thresholds expected to emerge? Value Health. 2004;5:518–528.
Kawasoe, H, Eguchi, Y, Mizuta, T, et al.
Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr. 2007;1:66–72.